Ra Pharmaceuticals, Inc.

CIK 1481512 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Ra Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Apr 13, 202015-12B0001104659-20-045640
Apr 8, 2020EFFECT9999999995-20-000702
Apr 6, 2020SC 13D/A0001072613-20-000155
Apr 3, 202040001104659-20-042761
Apr 3, 202040001104659-20-042771
Apr 3, 202040001104659-20-042764
Apr 3, 202040001104659-20-042762
Apr 3, 202010-K/A0001104659-20-043153
Apr 3, 202040001104659-20-042763
Apr 3, 202040001104659-20-042767
Apr 3, 202040001104659-20-042770
Apr 3, 202040001209191-20-022933
Apr 3, 202040001104659-20-042773
Apr 3, 202040001104659-20-042774
Apr 3, 202040001104659-20-042772
Apr 3, 202040001104659-20-042769
Apr 3, 202040001104659-20-042768
Apr 3, 202040001104659-20-042766
Apr 2, 2020S-8 POS0001104659-20-042448
Apr 2, 20208-K0001104659-20-042433
Apr 2, 2020S-8 POS0001104659-20-042454
Apr 2, 2020S-8 POS0001104659-20-042455
Apr 2, 2020S-8 POS0001104659-20-042446
Apr 2, 202025-NSE0001354457-20-000136
Apr 2, 2020POS AM0001104659-20-042436